Details for New Drug Application (NDA): 016401
✉ Email this page to a colleague
NDA 016401 describes NEOPAP, which is a drug marketed by Polymedica and is included in one NDA. Additional details are available on the NEOPAP profile page.
The generic ingredient in NEOPAP is acetaminophen. There are sixty-six drug master file entries for this compound. Ninety-six suppliers are listed for this compound. Additional details are available on the acetaminophen profile page.
The generic ingredient in NEOPAP is acetaminophen. There are sixty-six drug master file entries for this compound. Ninety-six suppliers are listed for this compound. Additional details are available on the acetaminophen profile page.
Summary for 016401
| Tradename: | NEOPAP |
| Applicant: | Polymedica |
| Ingredient: | acetaminophen |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016401
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUPPOSITORY;RECTAL | Strength | 120MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
